Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium

PartnershipPositive

AI Analysis

Summary

Ginkgo Datapoints and Apheris announced the formation of the Antibody Developability Consortium with AbbVie, argenx, Lundbeck, and Takeda as founding members. The consortium aims to advance antibody development capabilities through collaborative efforts.

Importance:5/10

Sentiment:

0.40

partnershipconsortiumantibody_developmentcollaboration

Related Companies

$DNABW $ABBV $ARGX $HLUYY $TAK

Read the original article

Published by yahoo_finance on September 29, 2026 12:00 PM

Read Original